Detalhe da pesquisa
1.
Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry.
Gastric Cancer
; 27(1): 131-145, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37964032
2.
Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother
; 72(6): 1709-1723, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36625938
3.
Mild forms of thrombotic microangiopathy in patients with advanced pancreatic cancer receiving gemcitabine and nab-paclitaxel.
J Oncol Pharm Pract
; 29(3): 738-745, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35876362
4.
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Gastric Cancer
; 24(4): 926-936, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651195
5.
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
Gastric Cancer
; 24(2): 445-456, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32970266
6.
Insights into the Use of Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice.
Curr Treat Options Oncol
; 22(3): 26, 2021 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33635493
7.
Clinical impact of preoperative tumour contact with superior mesenteric-portal vein in patients with resectable pancreatic head cancer.
Langenbecks Arch Surg
; 406(5): 1443-1452, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33475833
8.
The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC).
Oncologist
; 25(3): e451-e459, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162804
9.
Opioid-Induced Constipation in Oncological Patients: New Strategies of Management.
Curr Treat Options Oncol
; 20(12): 91, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31853656
10.
Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.
Cancer Immunol Immunother
; 72(6): 1725-1726, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36809405
11.
Submucosal gland adenocarcinoma of the esophagus. A rare non-Barrett's associated tumor.
Gastroenterol Hepatol
; 44(5): 367-369, 2021 May.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-33187748
12.
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry.
Clin Transl Oncol
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38361134
13.
New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy.
Cancers (Basel)
; 15(4)2023 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831586
14.
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.
Ther Adv Med Oncol
; 15: 17588359231157641, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36895850
15.
ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma.
Clin Cancer Res
; 28(8): 1662-1671, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042699
16.
Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53-Mutated Metastatic Colorectal Cancer.
Cancers (Basel)
; 14(23)2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36497403
17.
Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors.
Cancers (Basel)
; 13(15)2021 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34359675
18.
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.
Ther Adv Med Oncol
; 13: 17588359211019672, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34211587
19.
ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer.
Cancers (Basel)
; 12(7)2020 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32674482
20.
Predictive and prognostic biomarkers in personalized gastrointestinal cancer treatment.
J Gastrointest Oncol
; 8(3): 405-417, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28736628